Vol 43, No 2 (2012)
Review
Published online: 2012-09-01
Current therapy of primary myelofibrosis
DOI: 10.1016/S0001-5814(12)32004-5
Acta Haematol Pol 2012;43(2):107-112.
Abstract
primary myelofibrosis (pmf) belongs to chronic myeloid neoplasms with the worst prognosis in terms of survival and quality of life. This article summarizes current knowledge on molecular and cytogenetic factors related with pmf, presents various stratifications, clinical systems and therapeutic options.
Keywords: primary myelofibrosischronic myeloproliferative neoplasms
